New Products

CINCINNATI — Prasco Labs will distribute an authorized generic for reducing serum phosphate in patients with end-stage renal disease under a contract with Shire, Prasco said Thursday.

The company, which focuses on authorized generic drugs, announced the deal for lanthanum carbonate chewable tablets in the 500-mg, 750-mg and 1,000-mg strengths. The drug is a version of Shire's Fosrenol. Authorized generics are branded drugs marketed under their generic names at a discounted price, usually through a third-party company under contract with the branded drug's manufacturer.

WEST COVINA, Calif. — Diabetes Care Partners has introduced a new telehealth diabetes self-management education program, the company said.

The West Covina, Calif.-based company announced the launch of DiabetesCareConnect at Eastern Plumas Health Care in Portola, Calif., supported by Telehealthdocs, a team of physicians and telemedicine specialists, and Telemed Management.

LAS VEGAS — Lansinoh Laboratories is expanding its product offering with six new items for mass outlets in 2014, which are being introduced this week at the ABC Kids Expo, the company announced Wednesday.  

The items are inspired by Lansinoh's new Pump-Store-Feed system, and are designed to make breastfeeding as convenient as possible. The new products include two breast pumps and a redesign of the Lansinoh mOmma bottle. 

ALBUQUERQUE, N.M. — Heel on Tuesday announced the launch of the Reboost product line, which includes four of the company’s homeopathic cold, cough and flu products. The line is now available at a variety of fine natural health stores and pharmacies, including Whole Foods Market and Sprouts Farmers Market.

PARSIPPANY, N.J. — Ricola on Tuesday added a new product to its line of uniquely effective herb drops — Extra Strength for powerful cough relief.

Extra Strength contains a blend of 10 natural Swiss Alpine herbs and a soothing syrup center that provides powerful cough relief with natural menthol.

DUBLIN — Actavis is hoping to become the first to market a generic version of a drug used to treat patients who have become dependent on opioid drugs, triggering a lawsuit from the branded drug's manufacturer.

The generic drug maker said it had filed a regulatory approval application with the Food and Drug Administration for buprenorphine hydrochloride and naloxone hydrochloride sublingual film in the 2-mg/0.5-mg and 8-mg/2-mg strengths. The drug is a generic version of Reckitt Benckiser's Suboxone.

JERUSALEM — The Food and Drug Administration has approved a new generic drug from Teva Pharmaceutical Industries for treating eye infections, the company said.

The Israeli drug maker announced the approval of the antibiotic drug tobramycin inhalation solution, a generic version of Novartis' Tobi.

Tobi has sales of about $350 million during the 12-month period that ended in June, according to IMS Health.

EWING, N.J. — The Food and Drug Administration has approved a new drug made by Antares Pharma for treating rheumatoid arthritis and psoriasis, the drug maker said Monday.